Skip to content

How Medical Marijuana Affects Men vs. Women

How Medical Marijuana Affects Men vs. Women

As expected, men and women differ in a multitude of ways, from genetic makeup and hormonal behavior to how we process information and emotionally respond. The differences in our makeup are the exact reason why any medical treatment, including medical marijuana, will have a diverse impact on men vs. women. Let’s take a closer look at what these varying effects are, why they exist, and the benefits medical marijuana can produce for patients.

Effects on Women

A patient’s hormonal levels are one of the biggest causes of varying experiences when using medical cannabis. For example, estrogen can magnify the effects THC has on the body, which results in a higher level of pain relief. At the same time, research has shown that the female body has an easier time adapting compared to men, resulting in a higher level of tolerance. Since women are observed to become tolerant of cannabis at a more accelerated rate, it’s suggested to continuously increase dosage levels to help maintain the same level of pain relief. Overall, varying levels of estrogen throughout a woman’s cycle result in inconsistent levels of pain relief, stronger adaption to the effects of cannabis, and a higher risk of experiencing side effects. That being said, medical cannabis should still be considered a viable option and alternative to more dangerous medicinal treatments like opioids.

Effects on Men

According to a pain-relief study conducted in 2016, men experience a greater level of pain relief from the use of medical marijuana compared to women. To compare, women experience greater pain relief during times of higher estrogen, while men encounter a more stable effect throughout time. Men are also less likely to become tolerant of their medical marijuana dosage, permitting for a more consistent treatment plan. Additionally, the male body tends to be less sensitive to the various side effects of medical marijuana. The only side effect that is commonly reported in men is an increase in appetite following the use of medical cannabis. To sum up, the male body is reported to have a more consistent level of pain relief, a gradual increase in tolerance and minimal side effects. Based on these observations, the difference of efficacies between men and women can be directly correlated to the varying hormonal levels that women experience throughout their cycle.

As the use of medical marijuana expands, it’s safe to say that there is still an abundance of research to be conducted. It’s important that as medical professionals, we understand the complexities of marijuana and how it may affect a diverse range of patients. If you’re interested in learning more about medical cannabis efficacies in men vs. women or any other patient demographics, sign up for Arfinn Med today! Once a member, you’ll be able to insert, track and report patient efficacy data and discuss treatment plans with peers around the country.

Sources:

https://www.eurekalert.org/pub_releases/2014-09/wsu-eic082814.php

https://www.ncbi.nlm.nih.gov/pubmed/27522535

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931555/

https://www.nature.com/articles/npp2017140

https://www.thegrowthop.com/cannabis-culture/how-cannabis-affects-men-and-women-differently

Stories you may be interested in

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

European Parliament Passes Cannabis Resolution, Joins WHO In Supporting Medical Marijuana

Following reports about the World Health Organization (WHO) recommending a rescheduling of cannabis and several of its key components under international drug treaties, the European Parliament voted on Wednesday on a resolution that would help advance medical cannabis in the countries that form the European Union. Read the full story here.
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Arfinn Med March Updates

We are very happy to announce the release of several new functions within the Arfinn Med Platform.  Those include: * Text message updates from patients regarding their treatments * Templating for exam notes  * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More

World Cancer Day – Shine a Light on the World

In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More

State Board of Health reviews timelines for establishing Mississippi medical marijuana program

JACKSON, Miss. (WLBT) – The blueprint for Mississippi’s medical marijuana program is Initiative 65 that voters approved in November. That contains detailed requirements and the clock is ticking to get it started. The State Board of Health met virtually Wednesday to discuss the groundwork of the medical marijuana program. “I do want to tell you…
Read More

Leave a Comment

You must be logged in to post a comment.